Therapeutics Supplements and Botanicals

Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats

Mohammadi S, Karimzadeh Bardei L, Hojati V, Ghorbani AG, Nabiuni M

Published October 2017 Cell Journal, 19(3), 425-433
DOI 10.22074/cellj.2017.4415 PMID 28836404 PMC PMC5570407

RRM Academy Synopsis

Curcumin cut insulin resistance and inflammation markers in PCOS rats

Curcumin lowered insulin resistance and inflammation markers in rats. The 90 rats formed control, sham, untreated and curcumin-treated groups. Estradiol valerate induced a model of polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS). The treated rats received curcumin at two doses for 14 days.

Key Findings

  • PCOS induction raised HOMA-IR, the insulin resistance index, compared with controls (P<0.001). Both curcumin doses lowered it compared with untreated PCOS rats (P<0.001).
  • PCOS induction raised interleukin-6 (IL-6) compared with controls (P<0.001). Curcumin lowered IL-6 at the lower dose (P<0.01) and the higher dose (P<0.001) compared with untreated PCOS rats.
  • PCOS induction raised C-reactive protein (CRP) compared with controls (P<0.001). CRP was lower in rats given the higher curcumin dose than in untreated PCOS rats (P<0.001).
  • Liver sections from untreated PCOS rats showed tissue necrosis and hyperemia. Curcumin-treated rats showed less necrosis, and the higher dose showed smooth cords of hepatocytes with visible cell boundaries.

Interpretation

This controlled animal study followed 90 female Wistar rats across control, sham, untreated PMOS / PCOS and curcumin-treated groups. Estradiol valerate injections induced the PMOS / PCOS model, and blood and liver samples were collected after 14 days of treatment. The authors note that further research should look at additional inflammatory markers and at links with infertility.

RRM Context

A 2026 Lancet consensus renamed PCOS as PMOS. The new name reflects a condition that involves several body systems. Restorative reproductive medicine looks for the causes behind each person's cycle problems. Insulin resistance is a metabolic feature linked to the condition. This paper measured insulin resistance (HOMA-IR) together with inflammation markers and liver findings.

Abstract

Objectives

Curcumin protects the liver against injury and fibrosis through suppressing hepatic inflammation, attenuating hepatic oxidative stress (OS), and inhibiting hepatic stellate cells (HSCs) activation. Non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) are considered as common metabolic disorders. Low-grade chronic inflammation with different markers, such as elevated C-reactive protein (CRP) and interleukin-6 (IL-6) levels, play a crucial role in PCOS. This study aimed to evaluate the therapeutic effects of curcumin on IL-6 and CRP levels as well as insulin resistance (IR) index on liver function in PCOS rats.

Materials and Methods

In this experimental study, 90 adult Wistar rats were divided into control (n=18), sham (n=18), PCOS (n=18) and curcumin-treated PCOS groups (n=36). PCOS group was injected subcutaneously with 2 mg estradio-valerate (E2V). After 60 days, PCOS group was treated with curcumin [100 and 300 mg/kg body weight (BW)] for 14 days and anesthetized by chloroform. Blood and liver samples were collected for histological and serological analyses. Data were analyzed using In-Stat 3 via one-way analysis of variance (ANOVA).

Results

Histological and serological analyses showed a reduction in number of necrotic cells, IR index, as well as IL-6 and CRP levels in PCOS rats that were treated with various concentrations of curcumin.

Conclusions

In this study, curcumin decreased liver inflammation by induction of insulin sensitivity and reduction of hepatic necrosis. Therefore, curcumin may be considered as protective factor against inflammatory state of PCOS.

Topics

Related research

Therapeutics › Supplements and Botanicals › Herbal and Botanical Products
Shima Mohammadi, Latifeh Karimzadeh Bardei, Vida Hojati, Azita Ghorbani Ghorbani, Mohammad Nabiuni
S Mohammadi, L Bardei, V Hojati, A Ghorbani, M Nabiuni
PMID 28836404 28836404 DOI 10.22074/cellj.2017.4415 10.22074/cellj.2017.4415 Mohammadi et al. 2017, Mohammadi 2017